Skip to main content
Premium Trial:

Request an Annual Quote

A Bargain Made

Ananyo Bhattacharya writes at The Guardian 's Notes & Theories blog that conventional thinking in science policy says that "research lay at the heart of sustainable economic growth and should serve the public interest." Because of this, Bhattacharya says, researchers have made a "devil's bargain with the state [that] has led to a narrowly utilitarian view of science that dramatically undervalues basic research." Too close a relationship between science and business could discourage would-be researchers from pursuing science as a career, and deter those who do from pursuing problems they find interesting, he adds.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.